TARDBP and Alzheimer disease: For instance, APOE4 allele carriers exhibit accelerated amyloid-beta accumulation and reduced response to anti-Aβ therapies in Alzheimer’s disease [119,120], while TARDBP mutations drive TDP-43 proteinopathy in familial ALS, necessitating gene-targeted approaches [124,125].